Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Exchange Rate Effect (2016 - 2025)

Traws Pharma (TRAW) has disclosed Exchange Rate Effect for 13 consecutive years, with -$3000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Exchange Rate Effect changed N/A to -$3000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $39000.0, a 1400.0% increase, with the full-year FY2024 number at -$19000.0, down 290.0% from a year prior.
  • Exchange Rate Effect was -$3000.0 for Q3 2025 at Traws Pharma, down from $28000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $28000.0 in Q4 2022 to a low of -$20000.0 in Q2 2022.
  • A 5-year average of -$444.44 and a median of -$3000.0 in 2024 define the central range for Exchange Rate Effect.
  • Peak YoY movement for Exchange Rate Effect: plummeted 600.0% in 2022, then skyrocketed 1033.33% in 2025.
  • Traws Pharma's Exchange Rate Effect stood at -$8000.0 in 2021, then soared by 450.0% to $28000.0 in 2022, then plummeted by 75.0% to $7000.0 in 2023, then plummeted by 228.57% to -$9000.0 in 2024, then soared by 66.67% to -$3000.0 in 2025.
  • Per Business Quant, the three most recent readings for TRAW's Exchange Rate Effect are -$3000.0 (Q3 2025), $28000.0 (Q2 2025), and $23000.0 (Q1 2025).